1. Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo
   JIA LIU et al, 2015, Oncology Reports CrossRef
2. NOB1 silencing inhibits the growth and metastasis of laryngeal cancer cells through the regulation of JNK signaling pathway
   XIN GAO et al, 2016, Oncology Reports CrossRef
3. Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer
   Ranran Kong et al, 2017, Oncology Reports CrossRef
4. Effects of NOB1 on the pathogenesis of osteosarcoma and its expression on the chemosensitivity to cisplatin
   Leiming Luo et al, 2018, Oncology Letters CrossRef
5. MicroRNA-363-3p downregulation in papillary thyroid cancer inhibits tumor progression by targeting NOB1
   Su Dong et al, 2021, Journal of Investigative Medicine CrossRef
6. Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance
   Amr R. Elhamamsy et al, 2022, Cancer Research CrossRef
7. MicroRNA-326 functions as a tumor suppressor in colorectal cancer by targeting the nin one binding protein
   LEI WU et al, 2015, Oncology Reports CrossRef
8. Silencing NOB1 Can Affect Cell Proliferation and Apoptosis Via the C-Jun N-Terminal Kinase Pathway in Colorectal Cancer
   Zhong Ren et al, 2021, Journal of Investigative Surgery CrossRef
9. Establishment of a Novel Monoclonal Antibody L6 Specific to NOB1
   Yubo Ma et al, 2016, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy CrossRef
10. MicroRNA‑744 suppresses cell proliferation and invasion of papillary thyroid cancer by directly targeting NOB1
    Haixia Liu et al, 2019, Molecular Medicine Reports CrossRef
11. NOB1: A Potential Biomarker or Target in Cancer
    Weiwei Ke et al, 2019, Current Drug Targets CrossRef